(Q35738166)

10 August 2017

title

Therapeutic yield and outcomes of a community teaching hospital code stroke protocol (English)

1 reference

10 August 2017

Andrew W Asimos

1

1 reference

10 August 2017

H James Norton

series ordinal

2

1 reference

10 August 2017

Marlow F Price

series ordinal

3

1 reference

10 August 2017

Wilkie M Cheek

series ordinal

4

1 reference

10 August 2017

publication date

1 April 2004

1 reference

Academic Emergency Medicine

10 August 2017

published in

1 reference

10 August 2017

volume

11

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

361-370

1 reference

Effects of a specialized team on stroke care. The first two years of the Yale Stroke Program.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Intravenous thrombolysis for acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Intravenous t-PA for acute ischemic stroke: therapeutic yield of a stroke code system

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Early intravenous thrombolysis for acute ischemic stroke in a community-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Brain capillary tissue plasminogen activator in a diabetes stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH, and infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Implementation of an acute stroke program decreases hospitalization costs and length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke St

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Code stroke. An attempt to shorten inhospital therapeutic delays

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Treating acute stroke patients with intravenous tPA. The OSF stroke network experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

Fatal strokes in hyperglycemic cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1197%2FJ.AEM.2003.12.016

10.1197/J.AEM.2003.12.016

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference